Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SNNA

Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis

Sienna Biopharmaceuticals logo

About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)

Advanced Chart

Key Stats

Today's Range
$0.11
$0.17
50-Day Range
$0.14
$0.14
52-Week Range
$0.06
$3.80
Volume
13.32 million shs
Average Volume
1.87 million shs
Market Capitalization
$4.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SNNA Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
See More Headlines

SNNA Stock Analysis - Frequently Asked Questions

Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) released its quarterly earnings results on Thursday, March, 14th. The company reported ($0.93) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10.

Sienna Biopharmaceuticals (SNNA) raised $64 million in an IPO on Thursday, July 27th 2017. The company issued 4,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Protalix BioTherapeutics (PLX), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Motif Bio (MTFB) and Ritter Pharmaceuticals (RTTR).

Company Calendar

Last Earnings
3/14/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNNA
CIK
1656328
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$73.47 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.27 per share
Price / Book
0.11

Miscellaneous

Free Float
N/A
Market Cap
$4.20 million
Optionable
Not Optionable
Beta
2.67
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SNNA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners